tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jennifer Kim, 49 are a BUY (98%), 1 are a HOLD (2%).
Analyst Jennifer Kim, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 23.33% that have a potential upside of 30.72% achieved within 158 days.
Jennifer Kim’s has documented 81 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BLTE, Belite Bio ADR at 24-Nov-2025.
Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for INSM (INSMED) at 10/28/2025. The price target of $192 was fulfilled within 2 days with a profit of $26.71 (16.16%) receiving and performance score of 80.8.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 13-Jan-2025
$4.8
$0.54 (12.68%)
$4.8
9 months 11 days ago
(31-Mar-2025)
0/3 (0%)
$0.76 (18.81%)
Hold
Since 11-Mar-2025
$4.1
$-0.16 (-3.76%)
10 months ago
(11-Mar-2025)
1/4 (25%)
$0.1 (2.50%)
45
Hold
Since 10-Mar-2025
$4.1
$-0.16 (-3.76%)
$8
10 months 1 days ago
(10-Mar-2025)
2/4 (50%)
$0.12 (3.02%)
117
Buy
Since 19-Jan-2021
2 years 4 months 27 days ago
(15-Aug-2023)
0/2 (0%)
$8.34 (125.23%)
Which stock is Jennifer Kim is most bullish on?
Which stock is Jennifer Kim is most reserved on?
What Year was the first public recommendation made by Jennifer Kim?
